Exelixis | Capitalização De Mercado



Market Capitalization Alterar Data
Acadia Pharmaceuticals USD 3.05B 502M 2024-12
Agios Pharmaceuticals USD 1.87B 654M 2024-12
Amgen USD 139.96B 33.39B 2024-12
AstraZeneca GBP 162.31B 17.34B 2024-12
BioMarin Pharmaceutical USD 12.54B 855M 2024-12
Bristol-Myers Squibb USD 114.71B 9.82B 2024-12
Cytokinetics USD 5.55B 661M 2024-12
Eisai JPY 1.26T 322.6B 2024-12
Eli Lilly USD 732.87B 109.15B 2024-12
Genmab DKK 98.78B 8.42B 2024-12
Incyte USD 13.31B 575M 2024-12
Ionis Pharmaceuticals USD 5.52B 791M 2024-12
Merck USD 251.65B 36.21B 2024-12
Moderna USD 16B 9.69B 2024-12
Neurocrine Biosciences USD 13.82B 2.18B 2024-12
Novartis CHF 194.25B 18.5B 2024-12
Pfizer USD 150.34B 13.65B 2024-12
Takeda JPY 6.61T 16.72B 2024-12
Ultragenyx Pharmaceutical USD 3.88B 1.24B 2024-12
Xencor USD 1.61B 203M 2024-12



Exelixis Capitalização De Mercado - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2025.